RxDoctor Payments Data

Saqib Rehman, MD

Orthopaedic Surgery · Philadelphia, PANPI 1407844376

Payments from drug & device makers

$137,212in general payments, 2019–2025

Across 87 payments — averaging $1577.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$86K
  • Globus Medical$31K
  • Synthes GmbH$13K
  • Synthes USA Products LLC$6K
  • Stryker$634
  • Liberty Surgical Inc.$517
  • plus $777 from 3 others

What the payments were for

  • Royalty or licence$20,75739%
  • Consulting fees$12,60823%
  • Speaking & faculty fees$12,00022%
  • Travel & lodging$6,05611%
  • Food & beverage$1,9744%
  • Education$5171%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.22$85,735
Globus Medical31$30,684
Synthes GmbH17$12,863
Synthes USA Products LLC8$6,002
Stryker5$634
Liberty Surgical Inc.1$517
Orthoxel Designated Activity Company1$500
Curvafix, Inc.1$144
Vapotherm Inc1$132

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$137,212 in reported general payments places this provider in the 90th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$40,347
Medicare patients
80
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam12$38
Oxycodone Hcl20$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →